Background: Human polyomavirus (HPyV)6 and HPyV7 are shed chronically from human skin. HPyV7, but not HPyV6, has been linked to a pruritic skin eruption of immunosuppression.
H uman polyomaviruses (HPyVs) were first described in 1971, when JC polyomavirus and BK polyomavirus were identified in immunosuppressed individuals with ureteral obstruction and progressive multifocal leukoencephalopathy. 1, 2 In the past decade, an additional 11
HPyVs were described. 3 Of these, several appear to reside chronically in human skin: Merkel cell polyomavirus (MCV), trichodysplasia spinulosa polyomavirus, HPyV6, and HPyV7. MCV was discovered within, and was strongly linked to the pathogenesis of, a rare but deadly skin malignancy, Merkel cell carcinoma. 4 Trichodysplasia spinulosa polyomavirus was linked to a folliculocentric eruption first described in an immunosuppressed individual. 5, 6 HPyV6 and HPyV7 are closely related polyomavirus species first identified through rolling circle amplification of DNA isolated from swabs of healthy human skin. 7 They are thought to infect the skin in a latent or subclinical manner in the majority of people. In healthy individuals with clinically normal-appearing skin, previous studies detected HPyV6 and HPyV7 sequences from skin swabs in 14% to 28% and 11% to 13% of samples, respectively. 7, 8 Less is known about skin diseases associated with HPyV6 and HPyV7. Recent studies revealed that HPyV7 could infect and actively replicate in biopsy specimens taken from immunosuppressed lung transplant recipients. In these patients, the skin infection presented as pruritic, scaly, brown plaques. Biopsy specimens from lesional skin showed a characteristic pattern of parakeratosis described as ''peacock plumage.'' 9 In contrast to HPyV7, HPyV6 has not yet been linked with specific skin disease. Low levels of HPyV6 DNA were detected in several types of epithelial neoplasms and a contribution of HPyV6 to these neoplasms has not been excluded. 10, 11 We identify biopsy specimens showing a characteristic pattern of dyskeratosis and parakeratosis, previously described as ''peacock plumage,'' for HPyV7 skin infections and investigate whether polyomavirus infections might be associated with these eruptions. We identify HPyV6 and HPyV7 infection in 3 additional patients with pruritic dermatoses and provide evidence for the involvement of these viruses in the pathogenesis of the eruptions. 12, 13 Our work expands the spectrum of skin diseases associated with HPyV6 and HPyV7 and yields novel insights into the biology of these ubiquitous skin polyomaviruses.
METHODS
This was a retrospective case series of archived skin biopsy specimens. Histologically normal-appearing skin and archived biopsy samples were obtained through an institutional review boardeexempt protocol. For patient B, written, informed consent was obtained for collecting skin swabs for diagnostic and research purposes.
HPyV polymerase chain reaction
Formalin-fixed, paraffin-embedded (FFPE) sections were deparaffinized with xylene (Sigma, St Louis, MO) and DNA was extracted using the QIAamp DNA FFPE tissue kit (Qiagen, Hilden, Germany). Typically, polymerase chain reaction (PCR) was performed on 20 ng of genomic DNA with polyomavirus screening primers (Supplemental Table I 7,9,14-17 ; available at http://www.jaad. org). Quantitative PCR (qPCR) was used to determine the copy number of HPyV6, HPyV7, and MCV using SYBR green (Bio-Rad, Hercules, CA) and primers targeting the small T-antigen region. Long interspersed nuclear elements (LINE-1) primers were used as a normalization reference. Anonymized skin biopsy specimens from 8 patients with histologically normal-appearing skin were assessed by qPCR as a control. 
Histology

Electron microscopy
Biopsy specimens were deparaffinized in xylene, dehydrated, and placed in Trump fixative. The tissue was treated with osmium tetroxide, 2% uranyl acetate, rinsed, and dehydrated in alcohol. The tissue was embedded in epoxy resin, and thick and thin sections were generated and stained with toluidine blue (with sodium borate).
HPyV6 and HPyV7 genome sequencing
PCR was performed in a total volume of 50 L with 20 ng of DNA using Sapphire Amp Fast PCR master mix (Takara Bio Inc, Shiga, Japan) and 0.3 mol/L of sequence-specific primers (Supplemental Table I ). Additional HPyV6 sequencing primers were designed with Primer3 (NCBI, Bethesda, MD) to ensure overlapping coverage of the genome. Reactions were denatured at 958C for 5 minutes, followed by 35 cycles with denaturation at 958C for 1 minute, annealing at 568C for 1 minute, and extension at 728C for 2 minutes. Amplification products were agarose gelpurified with the NucleoSpin Gel and PCR clean-up kits (Machery-Nagel, D€ uren, Germany) and sent for bidirectional Sanger (GeneWiz, South Plainfield, NJ). Methods for unbiased sequencing of circular DNA viruses were previously described. 7, 18 Briefly, skin swabs were layered onto an Optiprep (Sigma) gradient, centrifuged to purify encapsidated virions, Benzonase Nuclease (Sigma) digested, and amplified by rolling circle amplification before whole genome sequencing.
RESULTS
The clinical characteristics of the patients, which have been previously reported, are summarized in Table I . 12, 13 All 3 patients presented with generalized, scaly, hyperpigmented papules coalescing into plaques, which were all present for at least 12 months. All dermatoses were associated with some degree of pruritus (Fig 1, A, and Table I ). Although patient A was immunosuppressed from HIV that had progressed to AIDS, patient C was immunosuppressed from a kidney/pancreas transplant. Curiously, patient B did not report any known immunosuppression at the time of initial diagnosis and biopsy in 2008. Importantly, all cases were first identified through biopsy specimens that showed a characteristic histologic pattern: scattered dyskeratotic cells throughout the epidermis along with irregular columns of parakeratosis in the stratum corneum (Fig 1, B) . This pattern has been described in the literature as ''columnar dyskeratosis,'' ''tiered parakeratosis with dyskeratosis,'' or ''peacock plumage.'' 9,12,13 FFPE lesional skin biopsy samples from these patients were screened for known HPyVs by end point PCR. Sample A amplified HPyV7, whereas samples B and C amplified HPyV6 (Fig 1,  C ) . Weaker bands consistent with MCV were detected in samples A and C in replicate experiments; however, MCV was not detected by qPCR (data not shown). We identified 3 additional cases that showed peacock plumage on histology. However, none of those cases showed evidence of HPyV6 or HPyV7 by PCR (data not shown), suggesting that this histologic pattern is not pathognomonic for polyomavirus infection. Classically, electron microscopy has been used to identify virions in tissues with suspected polyomavirus infections. Electron microscopy sections were prepared from samples A and B; insufficient tissue remained from sample C for processing. Although no viral particles could be identified from sample A, the biopsy specimen from patient B revealed cytoplasmic arrays of icosahedral structures approximately 40 nm in size, consistent with the reported size of polyomavirus virions (Fig 1, D) . The viral particles in sample B were identified in cells without recognizable features.
To confirm the expression of viral proteins in lesional skin, sections were stained with antibodies recognizing HPyV6 and HPyV7 capsid and small Tantigen proteins. T-antigen expression was detected in scattered cells throughout all levels of the epidermis. In contrast, capsid protein expression appeared to be enriched in the upper layers of the epidermis including within parakeratotic cells in the stratum corneum (Fig 2, A and B) . Viral capsid could be detected in both the nucleus and cytoplasm of infected cells (Fig 2, C ) , whereas T-antigen expression was largely limited to the nucleus of infected cells (Fig 2, D) . At higher magnification, the clear presence of desmosomes between infected cells provided histologic confirmation that keratinocytes could support active HPyV7 replication (Fig 2, D) . To better characterize the skin infections caused by HPyV6 and HPyV7, sections from patient A were costained with antibodies against viral antigensecapsid or small T-and cell-type-specific proteinseCK10 (a marker of more differentiated keratinocytes), CK14 (a marker of basal keratinocytes), or vimentin (a mesenchymal/fibroblast marker). The majority of viral antigen-positive cells costained for CK10 (66.7%) (Fig 3, A) or CK14 (91.6%) (Fig 3, B) , whereas a very small number of cells also appeared to stain positively for vimentin (6.4%) (Fig 3, C ) . These findings confirm that HPyV7 productively infects keratinocytes. Interestingly, we frequently noted the presence of CK10-negative, capsid-positive cells in the upper layers of the epidermis (Fig 3, A) .
Because HPyV6 and HPyV7 can be detected at low levels in clinically normal-appearing skin from healthy individuals, 8 we performed qPCR and sequencing to better characterize the HPyV6 and HPyV7 infections. DNA extracted from 2 distinct lesional biopsy specimens from patient A revealed an average HPyV7 load of ;2904 copies/LINE repeat (a normalization control). In contrast, a collection of skin biopsy specimens from asymptomatic skin donors (n = 8) showed an average of ;14.3 copies/LINE repeat. Patient B was calculated to have a mean HPyV6 load of ;1.44 3 10 6 copies/ LINE repeat, and patient C, ;2.37 3 10 6 copies/LINE repeat. In contrast, control samples showed an average of ;31.1 copies/LINE repeat (Fig 4, A) . Thus, the levels of HPyV6 and HPyV7 detected in multiple independent lesional biopsy specimens were found to be several orders of magnitude more abundant than in healthy skin controls, suggesting a possible pathogenic role for the virus in the described rashes. The complete genomes of HPyV7 and HPyV6 (GenBank KX771234-5), respectively, were successfully sequenced through primer walking. These sequences clearly diverged from published genomes (Fig 4, B, and Supplemental Table II ; available at http://www.jaad.org). Specifically, the HPyV6 strain present in patient B demonstrated a complex deletion/insertion in the noncoding control region (NCCR) along with multiple nucleotide substitutions in the NCCR, major capsid protein VP1, and large T-antigen regions. The HPyV7 strain from patient A had a deletion in the NCCR and nucleotide substitutions in major capsid proteins VP1/2/3 and large T-antigen regions. The possible effects of the mutations in the NCCR, capsid proteins, and large T antigens on viral replication and virulence are yet to be determined. Moreover, swabs collected from patient B in July 2016, after the dyskeratotic dermatoses had resolved, were analyzed through unbiased deep sequencing of encapsidated, circular DNA viruses. 7, 18 In addition to abundant reads representing the complete genomes of 9 human papillomaviruses and a MCV strain (GenBank KX781279-88), 121 reads matching HPyV6 isolate UTSW6.1 were observed (Fig 4, C ) . The results show that patient B continued to shed HPyV6 (alongside other typical members of the human skin virome) after resolution of symptoms.
DISCUSSION
Ho et al 9 first associated HPyV7 infection with pruritic rashes in immunosuppressed transplant recipients with a characteristic peacock plumage histology. Our study confirms and extends these seminal findings by linking HPyV6 with similar rashes. This study also broadens the range of immunosuppressed states that may allow for HPyV7 infection from iatrogenic immunosuppression from organ transplantation to the immunocompromised state of HIV infection. Of note, the patient with HIV described here was noted to have several types of human papillomavirus by PCR and was given a diagnosis of a variant of epidermodysplasia verruciformis. 13 Although the data here suggest that HPyV7 infection contributed significantly to the patient's disease, human papillomavirus coinfection could also contribute to the patient's clinical and histologic findings. Curiously, patient B in this study was not reported to be immunosuppressed at the time of the original biopsies. However, we speculate that the patient may have an uncharacterized, acquired immunosuppression based on his recent, frequent hospitalizations for severe infections. 12 Images from the HIV/AIDS patient (Patient A) are not shown as they have previously been published. 13 B, From patient B, on routine sections, there is mild acanthosis and papillomatosis (top); several dyskeratotic cells are noted in the superficial epidermis (arrows), with eosinophilic, nucleated keratinocytes forming irregular columns of parakeratosis (arrowheads) in the stratum corneum (middle). From patient C, an area with prominent columnar dyskeratosis showing dyskeratotic cells (arrows) and nucleated keratinocytes in the stratum corneum (arrowheads) (bottom). (B, Hematoxylin-eosin stain; original magnifications: top, 340; middle and bottom, 3200.) C, Polymerase chain reaction for HPyVs yielded specific bands for HPyV7 (arrow) and HPyV6 (arrowhead ). D, Electron microscopy of affected cells revealed numerous cytoplasmic ;40-nm icosahedral virions from patient B (original direct magnification: 318,000). HPyV, Human polyomavirus; MCV, Merkel cell polyomavirus.
These studies also expand our understanding of the biology of HPyV7. First, we definitively identify keratinocytes as the primary targets of HPyV7 infection in the skin. Although MCV, trichodysplasia spinulosa polyomavirus, HPyV9, and HPyV10 DNA can be detected on the skin, 8, 19 no other polyomaviruses have been demonstrated to infect nonfollicular keratinocytes. Given the detection of HPyV6 and HPyV7 in other tissues, 20, 21 it is likely that HPyV6 and HPyV7 can infect or remain latent in nonepidermal tissues, as is the case for other polyomaviruses. Our studies also suggest that, like other HPyVs, HPyV6 may persist as a latent infection in patients without clinical evidence of disease. Specifically, patient B possessed detectable levels of HPyV6 on his skin despite the fact that his pruritic dermatosis had resolved. How polyomaviruses, including HPyV6 and HPyV7, maintain latency remains unclear. The decreased expression of CK10 in some HPyV7-infected keratinocytes, in concert with the notable dyskeratosis in these infections, suggests that latent infections might be maintained, in part, through the inhibition of normal keratinocyte differentiation. Moreover, the numerous sequence changes in the strains identified in our work could also contribute to the virulence and/or persistence of these strains and deserve further investigation.
Because our case series is very small and largely retrospective in nature, additional cases showing HPyV6 and HPyV7 infection are necessary to confirm our findings. Moreover, the limited number of cases prevents us from definitively assigning causation to HPyV6 and HPyV7. We speculate that additional cases of HPyV6-and HPyV7-associated pruritic and dyskeratotic dermatoses will be identified based on the characteristic peacock plumage histologic pattern, in which nucleated, eosinophilic keratinocytes are present within the stratum corneum. In future studies, it will be interesting to investigate whether patients previously given a diagnosis of epidermodysplasia verruciformis show clinical or histologic changes consistent with the polyomavirus infections described here. Cases showing the characteristic histology could then be further screened for the presence of HPyVs, especially HPyV6 and HPyV7.
In summary, we provide multiple lines of evidence to suggest that highly active HPyV6 and HPyV7 infections are associated with skin disease, including high viral copy number in lesional skin, the expression of viral proteins by immunohistochemistry in dyskeratotic keratinocytes, and the detection of encapsidated virions by both electron microscopy and unbiased sequencing. Given the characteristic clinical and histologic presentation of these rashes, we propose that these skin diseases be described as HPyV6-and HPyV7-associated pruritic and dyskeratotic dermatoses. These rare conditions could be included in the differential diagnosis of immunosuppressed patients with recalcitrant, pruritic rashes. The identification of additional cases would be an important step toward improving our understanding of HPyV biology and ultimately developing better treatments for their associated diseases.
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